SEC Form 4 · accession 0001209191-18-062119
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc D Kozin
Director
Period of report
Dec 7, 2018
Accepted (ET)
Dec 11, 2018 · 7:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001544227
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Dec 7, 2018 | A | 831 | $0.00 | A | 7,740 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.
- F2Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.